Registry of Lobbyists

Monthly Communication Report

Return to Sommaire de 12 mois d'activités de lobbying - Sysco Canada Inc.

5088-575301

Corporation: GlaxoSmithKline
Associated registration: 953603-5088-57
Communication date: 2023-08-24
Posted date: 2023-09-15

Designated Public Office Holders who participated in the communication: Jocelyn Milburn, Director, Office of Life Sciences and Biomanufacturing Readiness
Innovation, Sciences et Développement économique Canada (ISDE)

Celine Menard, Director General
Financial Analysis and Oversight Branch, Innovation, Sciences et Développement économique Canada (ISDE)

Eric Bourbonnais, Director, Investment Opportunities
Strategic Innovation Fund, Innovation, Sciences et Développement économique Canada (ISDE)
 
Subject Matter of the communication: Développement économique,  Santé
 
Responsible Officer who filed this communication report: Sridhar Venkatesh
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Return to Sommaire de 12 mois d'activités de lobbying - Sysco Canada Inc.
Date Modified: